Skip to main content

Table 3 Numeric and percentage distribution of the participants regarding their therapeutic follow-up during COVID-19 pandemic (n = 1633)

From: Diabetes self-care practices and resilience in the Brazilian COVID-19 pandemic: results of a web survey: DIABETESvid

 

Total

Type 1 diabetes

Type 2 diabetes

Other types

P value*

 

n = 1633

%

n = 805

%

n = 628

%

n = 200

%

 

Have Private healthcare insurance

1121

68.65

596

74.0

412

65.6

113

56.5

 < 0.0001

Types of follow-up healthcare services for diabetes

         

 Public Primary Care

294

18.0

136

16.9

121

19.3

37

18.5

0.5006

 Public specialised outpatient clinics

113

6.9

82

10.2

22

3.5

9

4.5

 < 0.0001

 Private healthcare service or private healthcare insurance

856

52.4

480

59.6

288

45.9

88

44.0

 < 0.0001

 No presencial appointments since March 2020

455

27.9

181

22.5

217

34.5

57

28.5

 < 0.0001

Had telemedicine appointments

518

31.7

319

39.6

160

25.5

39

19.5

 < 0.0001

Professionals offering telemedicine services (n = 518)

         

 Physician

476

29.1

294

36.5

144

22.9

38

19.0

 < 0.0001

 Nurse

37

2.3

26

3.2

8

1.3

3

1.5

0.0351

 Pharmacyst

45

2.8

22

2.7

21

3.3

2

1.0

0.2109

 Nutritionist

89

5.4

61

7.6

17

2.7

11

5.5

0.0003

 Physical educator

21

1.3

15

1.9

3

0.5

3

1.5

0.0666

 Psychologist

49

3.0

38

4.7

10

1.6

1

0.5

0.0002

 Physiotherapist

6

0.4

3

0.4

2

0.3

1

0.5

0.9334

 Other health professionals

23

1.4

11

1.4

10

1.6

2

1.0

0.8173

Medications used for diabetes control

         

 Insulin(s)

999

61.2

778

96.6

134

21.3

87

43.5

 < 0.0001

 Tablet(s)

779

47.7

87

10.8

586

93.3

106

53.0

 < 0.0001

 Non-insulin injetable medication

45

2.8

10

1.2

32

5.1

3

1.5

 < 0.0001

 No medication for diabetes

22

1.3

2

0.2

10

1.6

10

5.0

 < 0.0001

Site for delivery of diabetes medications

         

 Governamental pharmacies

703

43.0

466

57.9

186

29.6

51

25.5

 < 0.0001

 “Farmácia Popular do Brasil” Program

435

26.6

151

18.8

234

37.3

50

25.0

 < 0.0001

 Private pharmacies and drugstores

662

40.5

263

32.7

308

49.0

91

45.5

 < 0.0001

 Non-governmental organizations**

128

7.8

107

13.3

16

2.5

5

2.5

 < 0.0001

 Do not know

5

0.3

2

0.2

2

0.3

1

0.5

0.8449

Lack of any medication for diabetes during pandemic

161

9.9

102

12.7

45

7.2

14

7.0

 < 0.0001

  1. *Pearson’s chi-square test, comparing DM1 vs DM2 vs “other types”
  2. **Churches, associations and labour unions